|
|
||
|
|
United States Patent: 6,022,554 Inventors: Lee; Jung-Chung (San Jose, CA); Pushpala; Shamim (Sunnyvale, CA); Lee; Charles E. (Union City, CA)Assignee: American Home Products Corporation (Madison, NJ) Appl. No.: 990367Filed: December 15, 1997 This invention relates to coating formulations for coating sustained-release drug implants. The coating formulations are capable of formulations are capable of forming a porous film coat over a biologically active agent to provide a release of the active agent at a constant rate over a prolonged period of time. The pore forming agent is used in the formulation of the invention in the amount effective to regulate the release of a biologically active compound at a desired rate. Preferably, the effective amount of the pore forming agent provides long term delivery of the active agent. The invention also provides an improved implant for the sustained administration of a biologically active compound suitable for subcutaneous implantation. The invention also relates to methods for making and using the formulation and the implant of the invention. SUMMARY OF THE INVENTION This invention encompasses novel coating formulations for
coating sustained-release drug implants. The coating formulations are
capable of forming a porous film over a biologically active agent to
provide a release of the active agent at a constant rate over a prolonged
period of time. The formulation of the invention comprises a water soluble
pore forming agent, such as polyethylene glycol, mixed with a water
insoluble polymer. The pore forming agent is used in the formulation of
the invention in the amount effective to regulate the release of a
biologically active compound at a desired rate. The pore forming agent
leaches out through the film in situ, and thus creates a perforated film
around the implants which regulates the release rate of actives through
micro-channels. Preferably, the effective amount of the pore forming agent
provides long term delivery of the active agent. Claim 1 of 21 Claims 1. A long term sustained-release implant comprising:
____________________________________________
|
|
|